Efgartigimod in IVIG Dependent Myasthenia Gravis Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efgartigimod in IVIG Dependent Myasthenia Gravis Patients — Stella

Recruiting

Back to Myasthaenia Gravis trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

Canada

Clinique Neuro-Outaouais, Gatineau, Quebec

Key details

Phase

Large-scale testing

Sponsor

Clinique Neuro-Outaouais

Collaborators

argenx

Enrollment target

~30 participants

Started

February 2025

Primary completion

January 2027

Age range

18 Years – 80 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov